Bright Pink

Today, after 18 years of transforming breast and ovarian cancer awareness into action, Bright Pink proudly announces a $3.5M legacy gift to launch the Bright Pink Preventive Risk Outreach And Cascade Testing (PROACT) Program at Stanford Medicine. This transformative gift marks the close of our daily operations and entrusts the future of our mission to a team of leading experts in breast and ovarian health. ? Led by Dr. Allison Kurian and Dr. Jennifer Caswell-Jin of Stanford University, in collaboration with the University of Michigan, the PROACT Program will build on Bright Pink’s work using family health history to expand access to genetic testing. Through a proven online platform that makes sharing family health information—and acting on it—easier, faster, and more accessible than ever before, this program intends to empower families nationwide to understand and share their genetic risks and enable their loved ones to take life-saving action. ? As we reflect on all we’ve accomplished, we are filled with pride and gratitude for the Bright Pink community—the young women at the heart of our mission and the countless individuals and organizations who have championed it along the way. From our first 15 years serving millions of young women with life-saving education and resources to our recent work advancing health equity with our Mission Partners through the Bright Pink Venture Fund, our collective charge has remained the same: save young women's lives from breast and ovarian cancer through bold, innovative solutions. The PROACT Program intends to carry this legacy of life-saving impact forward and shape a better, brighter future for generations to come. ? For more information on Bright Pink's 18 years of impact, final chapter, and legacy gift visit: https://lnkd.in/gputsrks and visit https://proactprogram.org/ to visit the Bright Pink PROACT Program's new digital home on Stanford Medicine's site.